Surgery Doctors in Walla Walla, WA Accepting Medicare

5 Surgery doctors found. Showing 1 - 5

Ernest William Steinle, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 380 Chase Ave, Walla Walla, WA 99362 Phone: 509-522-5765    Fax: 509-522-5558

Dr. Frederick Ian Field, M.D., FACS Surgery - Vascular Surgery Medicare: Not Enrolled in Medicare Practice Location: 301 W Poplar St, Suite 50, Walla Walla, WA 99362 Phone: 509-522-5765    Fax: 509-522-5516

Scott G Newbold, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 55 W Tietan St, Walla Walla, WA 99362 Phone: 509-525-3720    Fax: 509-522-1592

Nicholas Michael, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 380 Chase Ave, Walla Walla, WA 99362 Phone: 509-897-3790

John P Shannon, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 301 W Poplar, Suite 210, Walla Walla, WA 99362 Phone: 509-522-5825    Fax: 509-529-3512

News Archive

Scientists study organ development in mice to unravel how breast cancers develop in people

Reviving a theory first proposed in the late 1800s that the development of organs in the normal embryo and the development of cancers are related, scientists at the Salk Institute for Biological Studies have studied organ development in mice to unravel how breast cancers, and perhaps other cancers, develop in people. Their findings provide new ways to predict and personalize the diagnosis and treatment of cancer.

CSIS releases compilation of papers on China's health, foreign aid engagement in Africa

The Center for Strategic & International Studies (CSIS) released a compilation of papers "focusing specifically on China's health and foreign aid engagement in Africa," which "includes contributions by U.S. and Chinese experts."

CytRx initiates aldoxorubicin Phase 2 trial in HIV-infected patients with Kaposi's sarcoma

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a Phase 2 clinical trial to determine preliminary efficacy and safety of aldoxorubicin for HIV-infected patients with Kaposi's sarcoma.

TissueGene commences enrollment in TG-C Phase II trial for severe knee osteoarthritis

TissueGene, Inc. announced today that it has initiated patient enrollment for a U.S. Phase II clinical trial of its lead product candidate TG-C. TG-C involves human allogeneic chondrocytes developed to produce the therapeutic protein TGF-beta1 for the regeneration of cartilage in patients suffering from severe osteoarthritis of the knee.

Research team identifies new roles for Huntington's Disease protein

A Duke University research team has identified a new function of a gene called huntingtin, a mutation of which underlies the progressive neurodegenerative disorder known as Huntington's Disease.

Read more Medical News

› Verified 7 days ago